91 related articles for article (PubMed ID: 8761437)
21. The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential.
Tsuda T; Marinetti MR; Masuelli L; Cutler ML
Oncogene; 1995 Jul; 11(2):397-403. PubMed ID: 7624154
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
23. Early genetic and functional events in the pathogenesis of oral cancer.
Prime SS; Eveson JW; Guest PG; Parkinson EK; Paterson IC
Radiat Oncol Investig; 1997; 5(3):93-6. PubMed ID: 9303062
[TBL] [Abstract][Full Text] [Related]
24. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
25. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
26. Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080.
Anderson MJ; Casey G; Fasching CL; Stanbridge EJ
Genes Chromosomes Cancer; 1994 Apr; 9(4):266-81. PubMed ID: 7519049
[TBL] [Abstract][Full Text] [Related]
27. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.
Zenklusen JC; Conti CJ; Green ED
Nat Genet; 2001 Apr; 27(4):392-8. PubMed ID: 11279520
[TBL] [Abstract][Full Text] [Related]
28. Molecular and functional analysis of tumor-suppressor genes by transfection.
Schäfer R; Iyer J; Iten E; Nirkko AC; Balmer J; Klemenz R
Environ Health Perspect; 1991 Jun; 93():79-82. PubMed ID: 1773805
[TBL] [Abstract][Full Text] [Related]
29. Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13.
Kehrmann A; Truong H; Repenning A; Boger R; Klein-Hitpass L; Pascheberg U; Beckmann A; Opalka B; Kleine-Lowinski K
Cancer Genet; 2013; 206(7-8):279-92. PubMed ID: 24042169
[TBL] [Abstract][Full Text] [Related]
30. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
31. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
32. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9.
Wu Q; Possati L; Montesi M; Gualandi F; Rimessi P; Morelli C; Trabanelli C; Barbanti-Brodano G
Int J Cancer; 1996 Mar; 65(6):840-6. PubMed ID: 8631601
[TBL] [Abstract][Full Text] [Related]
33. The role of the THY1 gene in human ovarian cancer suppression based on transfection studies.
Abeysinghe HR; Pollock SJ; Guckert NL; Veyberman Y; Keng P; Halterman M; Federoff HJ; Rosenblatt JP; Wang N
Cancer Genet Cytogenet; 2004 Feb; 149(1):1-10. PubMed ID: 15104276
[TBL] [Abstract][Full Text] [Related]
34. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
35. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
36. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Florenes VA; Fodstad O; Scanlon KJ
Cancer Res; 1994 Feb; 54(4):900-2. PubMed ID: 8313379
[TBL] [Abstract][Full Text] [Related]
37. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
38. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
39. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
Lebeau J; Le Chalony C; Prosperi MT; Goubin G
Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppression and potentiation by manipulation of pp32 expression.
Bai J; Brody JR; Kadkol SS; Pasternack GR
Oncogene; 2001 Apr; 20(17):2153-60. PubMed ID: 11360199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
